Other Clinical Trial - Clinical Trial to Evaluate the Efficacy & Safety of

See also
Status	Clinical Trial	Phase
Completed	`NCT03711292` - Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings	N/A
Not yet recruiting	`NCT03517215` - The Development and Testing of a Scaling Strategy for a Community-Based Primary Care Antimicrobial Stewardship Program	N/A
Completed	`NCT01420445` - Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis	Phase 2
Completed	`NCT00360464` - A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases	Phase 3
Completed	`NCT05344638` - A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis	Phase 3
Completed	`NCT06457269` - Evaluating the Potential of Large Language Models for Respiratory Disease Consultations	N/A
Completed	`NCT04239521` - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Recruiting	`NCT03827590` - Clinical Trials to Assess the Efficacy and Safety of HLIM	Phase 3
Completed	`NCT02792946` - Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis	Phase 3
Completed	`NCT01875757` - Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life	Phase 3
Recruiting	`NCT04252963` - Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)	Phase 4
Recruiting	`NCT06411925` - The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients	Phase 4
Completed	`NCT01416480` - Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher	Phase 3
Enrolling by invitation	`NCT05916768` - Management of Acute Bronchitis With Pelargonium Sidoides Extract	N/A
Completed	`NCT03309800` - A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients	Phase 2
Completed	`NCT02250027` - A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on)	Phase 2
Not yet recruiting	`NCT03310385` - Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis	Phase 2
Completed	`NCT03654196` - A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients	Phase 3
Completed	`NCT03011515` - Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)
Completed	`NCT02045394` - Epidemiology and Diagnosis of Haemoptysis: a Multicenter Study	N/A

NCT number	NCT04260555
Study type	Interventional
Source	Daewon Pharmaceutical Co., Ltd.
Contact
Status	Active, not recruiting
Phase	Phase 3
Start date	December 20, 2018
Completion date	February 28, 2021

Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms